Keywords
Anesthetic consideration; Arteriovenous fistula placement; End stage renal disease; Vascular access
Abstract
According to the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, the overall prevalence of chronic kidney disease is approximately 14 percent in the general population of the United States [1] This prevalence has remained relatively stable since 2004 [1] with approximately 468,000 Americans on dialysis as of 2015. [2] With diabetes and hypertension being the most common primary causes of End-Stage Renal Disease (ESRD), patients undergoing procedures for arteriovenous access tend to present with multiple co morbidities. For this specific patient population, these comorbidities may have specific anesthetic implications. This article focuses on the anesthetic considerations throughout the entire perioperatively period with special emphasis on the role of regional anesthesia.
Citation
Nguyen H, Pai SL, Thammasithiboon S and Gasanova I. Anesthetic Considerations for Vascular Access Placement in Patients with End-Stage Renal Disease. SM J Anesth. 2017; 3(1): 1010.